MPa Max adhesive
Den-Mat Holdings, LLC · Decision date Sep 24, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision for MPa Max adhesive, a Class II resin tooth bonding agent (21 CFR 872.3200, product code KLE), on September 24, 2026, under review panel Dental. The applicant is Den-Mat Holdings, LLC of Lompoc, California; the submission was received July 2, 2026, and the summary was prepared September 8, 2026. SESE denotes 510(k) clearance, not premarket approval.
The submission is a Traditional 510(k) citing Peak Universal Bond (K100752 as primary, K240743 as secondary) as predicates. The summary describes a bottle-delivered, 7.5% filled adhesive with an ethyl alcohol solvent carrier, 0.2% chlorhexidine, and a cured film thickness of approximately 2 µm, used with etch-and-rinse technique. The stated indications cover bonding to dentin, enamel, porcelain, zirconia, metal and composite. The summary states clinical testing was not required; the public record does not disclose the specific non-clinical test results.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Dental
- Decision date
- Sep 24, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K262252
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Den-Mat Holdings, LLC
- Product code
- KLE
- Decision code
- SESE
- Decision date
- Sep 24, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Agent, Tooth Bonding, Resin.
- Applicant
- Den-Mat Holdings, LLC
- Product code
- KLE
- FDA device class
- 2
FDA decision timeline
K262252 received
Application receipt date recorded by FDA.
K262252 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code KLE
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Dent4You AG | 510(k) clearance | Oct 8, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Den-Mat Holdings, LLC
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Lompoc, CA
Sources and methodology
- Original FDA record: K262252
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records